Abstract
With the expansion of domesticated microbes producing biomaterials and chemicals to support a growing circular bioeconomy, the variety of waste and sustainable substrates that can support microbial growth and production will also continue to expand. The diversity of these microbes also requires a range of compatible genetic tools to engineer improved robustness and economic viability. As we still do not fully understand the function of many genes in even highly studied model microbes, engineering improved microbial performance requires introducing genome-scale genetic modifications followed by screening or selecting mutants that enhance growth under prohibitive conditions encountered during production. These approaches include adaptive laboratory evolution, random or directed mutagenesis, transposon-mediated gene disruption, or CRISPR interference (CRISPRi). Although any of these approaches may be applicable for identifying engineering targets, here we focus on using CRISPRi to reduce the time required to engineer more robust microbes for industrial applications.
One-Sentence Summary
The development of genome scale CRISPR-based libraries in new microbes enables discovery of genetic factors linked to desired traits for engineering more robust microbial systems.
Keywords: Genome-scale screening, Synthetic biology, CRISPRi
Graphical Abstract
Graphical Abstract.
Introduction
As consumers realize the environmental and social effects of unsustainable industrial practices and change their purchasing behavior, it will be critical for all industries to explore and invest in sustainable practices (Bradu et al., 2023). The use of biological processes to alter industry away from the linear consumption of resources to one where reusability is a priority, defines the emerging circular bioeconomy (Hadley Kershaw et al., 2021). Microbes are critical for the development of a sustainable and resilient bioeconomy (Ma et al., 2022). In selecting a microbe for a particular industrial process, it is vital to ensure a base level of tolerance to conditions under which it will be applied, reducing the risk associated with attempting to adapt a model microorganism to harsh and inhospitable growth conditions such as low pH or high temperature (Liu et al., 2022). Transferring metabolic pathways of interest from undomesticated microbes into easy-to-manipulate hosts is also likely to introduce the need for adaptation due to redox imbalances or pathway intermediate/product toxicity. Here, we will discuss our perspective on the associated challenges with domesticating new microbes and the steps required to develop an unbiased, genome-scale, functional screen or selection that allows for efficient and rapid genotype-phenotype discovery in a microbe targeted for industrial applications (Fig. 1). We will also discuss the emerging need and potential for developing genetic tools applicable to a broader range of microbes, including extremophilic organisms.
Fig. 1.
Design-Build-Test-Learn (DBTL) tools toward a circular bioeconomy. Supporting a circular bioeconomy requires the utilization of a variety of unconventional feedstocks including waste streams and renewable feedstocks such as woody biomass. Environmental microbes provide a largely untapped source of enzymes and pathways towards utilization of these feedstocks and production of a wide variety of biochemicals and materials. Domesticating these microbes for industrialization requires effective characterization including genome sequencing and –omics analysis. With this information, genetic tools can be developed and applied towards engineering and implementation of functional genomic screens and selections to identify genotype-phenotype relationships to guide further engineering. This involves a DBTL strategy to inform the most efficient routes to domestication and industrialization and provides data for better predictive design. This increase in capabilities accelerates efforts towards sustainable industrial practices and generally improves understanding of microbial diversity.
Discussion
Microbial Isolate Characterization and Genetic Tool Development
Isolating microbes from conditions matching their intended industrial use environment, that is utilization of waste feedstocks, high temperature, high salt, or extreme pH, will ensure microbes have the necessary features for optimal growth and production to reduce time to economic viability. Exploring more extreme environments can also reveal metabolomic mechanisms that can be more easily adopted for industrial applications (Beloqui et al., 2008). The sequencing cost of third generation long-read technologies has continued to reduce and the quality and depth of data is sufficient for de novo genome and metagenome assemblies (Athanasopoulou et al., 2022). Combining long-read based genome assemblies with short-read polishing achieves high genome sequencing accuracy (Zhang et al., 2021) and reveals critical information about the accessible metabolic output present in newly isolated microbes. Initial metabolomic and proteomic surveys can additionally provide substantial functional information that is difficult to assess through genome sequencing alone (Bauermeister et al., 2022; Bludau & Aebersold, 2020).
Genetic manipulation of isolated microbes is indispensable for improving function in industrial applications (Becker & Wittmann, 2018). One barrier to genomic engineering efforts is the innate restriction-modification (R-M) systems found in most bacteria and archaea. Methylome sequencing using PacBio or ONT helps characterize DNA methyltransferases (MTases) that are active in each host (Crits-Christoph et al., 2023; Li et al., 2020; Tourancheau et al., 2021) and accounting for the methylation state of the host can provide immediate increases in transformation efficiency (Riley & Guss, 2021). Establishing functional genetic tools is the next critical step. These include, but are not limited to, compatible origins of replication, promoters, ribosome binding sites, and terminators to enable controlled maintenance and expression of genetic components (Freed et al., 2018). Chromosomal integration is also generally practical as replicating plasmids can be unstable and vary in copy number in host microbes. Integrated DNA is more stable in the host and reduces the need for antibiotic-based selection. Serine integrase and recombinase-based systems can remove host range limitations of a replicating plasmid and the efficiency of native homologous recombination to evaluate heterologous genes and pathways (Ba et al., 2023; Elmore et al., 2023).
Genome-scale Screening and Selection Methods
Genome-scale studies are an essential step in developing a host for industrial uses as they enable the identification of genetic factors associated with complex traits for strain optimization. There are a variety of methods that have been employed including adaptive laboratory evolution (Dragosits & Mattanovich, 2013; Lim et al., 2021; Mueller et al., 2022; Wang et al., 2023; Zhan et al., 2023), transposon-mediated gene disruption (Tn-Seq) (Bleem et al., 2023; Borchert et al., 2023; Price et al., 2018; Shields & Jensen, 2019; Wetmore et al., 2015), CRISPR-based modifications including interference (CRISPRi), CRISPR activation (CRISPRa), and base editing (Adli, 2018; Lee et al., 2019; Li et al., 2016; Liu et al., 2022; Saber Sichani et al., 2023; Silvis et al., 2021; Volke et al., 2023), and random mutagenesis (Freed et al., 2018; Riley & Guss, 2021). Herein we will focus on CRISPRi, a recently emerged robust functional genomic screening and selection method (Trivedi et al., 2023). CRISPRi is a gene repression technique that utilizes a catalytically inactive Cas9 nuclease (dCas9) complexed with a single-guide RNA (sgRNA), expressed from single gRNA bearing plasmids, that directs it to a targeted region in the genome, binds the DNA, and prevents transcription (Call & Andrews, 2022; Cho et al., 2018; de Bakker et al., 2022; Schultenkämper et al., 2020; Todor et al., 2021; Zhang et al., 2021). Inducible expression of dCas9 provides unique abilities not possible with other techniques such as TN-Seq, including probing essential genes and seeing a range in phenotypes resulting from varying levels of repression within the same gene targeted by multiple sgRNAs (Cui et al., 2018; Li et al., 2020; Rousset et al., 2018; Wang et al., 2018).
As with any experimental tool, there are limitations to dCas9 use that must be considered. One of the most frequently encountered issues is toxicity of dCas9 protein expression (Vento et al., 2019). Placing dCas9 under an inducible, titratable promoter is one strategy to alleviate this issue. Cas9 requires a three base pair (NGG) PAM (protospacer adjacent motif) that directly impacts the number of genomic sites available for binding, potentially limiting the number of gRNAs that can be targeted towards a particular gene (Collias & Beisel, 2021). Large amounts of engineering work to expand and alter PAM specifications has been done to address this limitation (Leenay & Beisel, 2017). Additionally, there is the potential for off-target knockdown effects plus a lack of generalizable gRNA design rules between species (Cui et al., 2018; Tadić et al., 2019). A few library design rules are vital in constructing a comprehensive and targeted genome-scale library. Excluding sgRNAs with overlapping seed region sequences helps prevent off-target effects and including enough sgRNAs (∼10) per gene in the library will ensure effective gene repression by at least one sgRNA, as a priori prediction of repression strength for individual sgRNAs is difficult. Additionally, multiple sgRNAs targeting each gene will reveal phenotypes resulting from varying levels of gene repression that might be missed by gene knockout or only one level of repression. As the available CRISPRi functional genomics datasets increase, refinements to general gRNA design rules, like those demonstrated for E. coli (Noshay et al., 2023; Yu et al., 2024), will improve CRISPRi experimental design for non-model microbes. Further, as more nucleases such as Cas12a are developed for genomic engineering applications (Ma et al., 2022), these proteins are being adopted as useful alternatives, should dCas9 expression toxicity pose an issue in a given system. The ability to multiplex gRNAs in a single array and utilize Cas12a in low-GC content non-model organisms has broadened the applicability of Cas-based functional genomic screens (Choi & Woo, 2020; Fleck & Grundner, 2021; Jervis et al., 2021; Joseph & Sandoval, 2023; Schilling et al., 2020). The development of other nucleases, such as Cas12a, will expand the knowledge gained from Cas-based transcriptional interference studies, thus bolstering the available data for metabolic engineering applications.
Sufficient transformation efficiency for adequate library coverage is also an important consideration when implementing CRISPRi libraries. For organisms with poor transformation efficiency, the size of an effectively transformable library will be limited. To achieve successful target suppression and realize the benefits of partial gene knockdowns, selecting fewer genes and providing sufficient sgRNA coverage across the target genes may be advantageous. Further, it is critical to make roughly ∼1% of the library non-targeting guides as an internal control for dCas9 toxicity. Well-designed CRISPRi libraries have been employed to study an ever-increasing number of biological phenomena, including improving growth on a desirable substrate, increasing product production, developing microbes as biosensors in the soil, and microfluidics for bioanalysis (Table 1).
Table 1.
Examples of CRISPRi Studies.
| Category | Application | Citation |
|---|---|---|
| Biosensors | 1. Metabolic flux control 2. Compound over-production 3. Pollution detection 4. Product formation detection 5. Compound tolerance analysis |
1. Chiang & Hasty (2023), Wu et al. (2020) 2. Peng et al. (2024), Shen et al. (2022), Wang et al. (2023) 3. Roy et al. (2021) 4. Henke et al. (2022) 5. Mormino et al. (2022) |
| Microfluidics | 1. High-titer protein production 2. Antibiotic resistance determination 3. Enzyme secretion 4. Increased compound production 5. Synthetic circuits 6. Study large-scale genotypic variation |
1. Li et al. (2016), Yu et al. (2023) 2. Kong et al. (2019) 3. Andreas Johansson et al. (2023) 4. Li et al. (2016) 5. Santos-Moreno et al. (2020) 6. Camsund et al. (2020) |
| Metabolic engineering | 1. Enhanced fatty alcohol production 2. Single-cell protein production 3. Alter metabolic flux/pathway engineering 4. Amino acid production 5. Terpenoid synthesis 6. Growth-product coupling and decoupling 7. Commodity chemical production |
1. Kaczmarzyk et al. (2018) 2. Balagurunathan et al. (2022) 3. Cho et al. (2018), Fenster et al. (2022), Lu et al. (2022), Xia et al. (2019), Zhao et al. (2021) 4. Yin et al. (2024) 5. Chu (2022) 6. Banerjee et al. (2020), Li et al. (2020) 7. Mougiakos et al. (2018) |
CRISPRi Screening and Selection
Experimental design is critical when setting up a pooled library selection or screen such as CRISPRi to ensure that unintended bias does not skew output data, leading to false positives or negatives. Therefore, carefully defining screen or selection conditions is one of the first considerations. For example, utilizing a carbon source without a defined composition will make assigning specific causes for observed phenotypes more challenging. Choosing a relatively straightforward or quantifiable phenotype such as survival, growth rate, or product output increases the interpretability of the selection or screen outcome. One can assess the effectiveness of the screen or selection by monitoring ‘known’ candidate hits with expected phenotypes (e.g. efflux pumps under antibiotic stress) (Kim et al., 2017). Initial analysis of CRISPRi screens or selections provides genome-wide expression knockdown to identify genotype-to-phenotype relationships more clearly. Genes of interest are identified by assessing the log2 fold change of the final abundance over the initial abundance for each sgRNA in the library as normalized by internal non-targeting gRNA controls and control library growth conditions. These data uncover specific gene knockdown enrichments or depletions reflecting changes in growth and survival under experimental conditions (Bock et al., 2022). Once these data are compiled and evaluated, subsequent validation of gene targets can be chosen to recapitulate the observed phenotype. These validation experiments may include individual and/or combinatorial gene knockdowns, promoter substitutions, or complete gene deletions and subsequent phenotypic evaluations such as proteomics, activity assays, and microscopy to identify modes for improved growth under the chosen growth conditions (Anglada-Girotto et al., 2022; Liu et al., 2017; Wang et al., 2023; Zhan et al., 2020).
Effective application of CRISPRi functional genomic analyses is dependent on well-developed genetic tools in the organism of interest (Yeom et al., 2023). Excellent transformation efficiency, well characterized plasmid components (origins of replication, selectable markers, and promoters) and genomic integration tools are critical for implementing well-designed experiments. As novel, extremophilic organisms, with few of the necessary genetic tools are adopted for industrial applications, it is essential to invest effort in developing the appropriate genetic toolkits.
Future Applications: Expanding Microbial Chassis
A growing number of industrially relevant microbes are emerging as production chassis using various carbon sources (Fatma et al., 2020; Heijstra et al., 2017; Nargotra et al., 2023). Industrial microbes will increasingly be isolated from extreme growth conditions to optimize industrial processes and decrease costs. Advantages of developing extremophiles for industrial applications include native production of thermostable enzymes with higher substrate solubility, higher conversion efficiency, increased reaction kinetics, and decreased risk of contamination (Zhu et al., 2020). Additionally, some feedstock substrates of interest, like polyethylene terephthalate, are not amenable to biological valorization at mesophilic temperatures (Orlando et al., 2023). Developing thermophilic microbes able to metabolize such substrates have the potential for improving resource recycling. Realizing the industrial potential of these microbes will require rapid development of amenable genetic tools. As it currently stands, there is a lack of broadly applicable genetic tools, including selectable markers, promoters, plasmid origins, and transformation protocols, as broadly utilized mesophilic tools are not functional in these thermophilic microbes (Y. Wang et al., 2024; Ye et al., 2023). While there are a growing number of tools being generated for use in thermophilic microbes (Adalsteinsson et al., 2021; Le & Sun, 2022; Riley et al., 2019; Walker et al., 2020; Wang et al., 2022; Wu et al., 2023; Yang et al., 2023), developing new tools and implementing CRISPR mediated genome engineering and/or thermostable serine recombinase-assisted genome engineering (SAGE) mediated integration would greatly simplify testing production of various industrial chemicals in these currently underutilized microbes (Fenster & Eckert, 2021; Wu et al., 2023). Continued decrease in -omics costs coupled with advanced genome modification techniques makes adopting extremophiles and other novel, less studied microbes as industrial chassis a viable and exciting avenue of research that should be more intensely pursued.
Acknowledgments
This manuscript has been authored by UT-Battelle, LLC under Contract No. DE-AC05-00OR22725 with the U.S. Department of Energy. The United States Government retains and the publisher, by accepting the article for publication, acknowledges that the United States Government retains a non-exclusive, paid-up, irrevocable, world-wide license to publish or reproduce the published form of this manuscript, or allow others to do so, for United States Government purposes. The Department of Energy will provide public access to these results of federally sponsored research in accordance with the DOE Public Access Plan (http://energy.gov/downloads/doe-public-access-plan).
Contributor Information
Margaret K Bales, Biosciences Division, Oak Ridge National Laboratory, Oak Ridge, TN 37831, USA; Bredesen Center for Interdisciplinary Research, Graduate School of Genome Science and Technology, University of Tennessee, Knoxville, TN 37996, USA; Center for Bioenergy Innovation, Oak Ridge National Laboratory, Oak Ridge, TN 37831, USA.
Michael Melesse Vergara, Biosciences Division, Oak Ridge National Laboratory, Oak Ridge, TN 37831, USA; Center for Bioenergy Innovation, Oak Ridge National Laboratory, Oak Ridge, TN 37831, USA.
Carrie A Eckert, Biosciences Division, Oak Ridge National Laboratory, Oak Ridge, TN 37831, USA; Bredesen Center for Interdisciplinary Research, Graduate School of Genome Science and Technology, University of Tennessee, Knoxville, TN 37996, USA; Center for Bioenergy Innovation, Oak Ridge National Laboratory, Oak Ridge, TN 37831, USA.
Funding
This material is based upon work supported by the Center for Bioenergy Innovation (CBI), U.S. Department of Energy, Office of Science, Biological and Environmental Research Program under Award Number ERKP886.
Conflict of Interest
All authors declare no conflict of interest.
References
- Adalsteinsson B. T., Kristjansdottir T., Merre W., Helleux A., Dusaucy J., Tourigny M., Fridjonsson O., Hreggvidsson G. O. (2021). Efficient genome editing of an extreme thermophile, Thermus thermophilus, using a thermostable Cas9 variant. Scientific Reports, 11 (1), 9586. 10.1038/s41598-021-89029-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Adli M. (2018). The CRISPR tool kit for genome editing and beyond. Nature Communications, 9 (1), 1911. 10.1038/s41467-018-04252-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Andreas Johansson S., Dulermo T., Jann C., D. Smith J., Pryszlak A., Pignede G., Schraivogel D., Colavizza D., Desfougères T., Rave C., Farwick A., A. Merten C., R. Roy K., Wei W., M. Steinmetz L. (2023). Large scale microfluidic CRISPR screening for increased amylase secretion in yeast. Lab on a Chip, 23 (16), 3704–3715. 10.1039/D3LC00111C [DOI] [PMC free article] [PubMed] [Google Scholar]
- Anglada-Girotto M., Handschin G., Ortmayr K., Campos A. I., Gillet L., Manfredi P., Mulholland C. V., Berney M., Jenal U., Picotti P., Zampieri M. (2022). Combining CRISPRi and metabolomics for functional annotation of compound libraries. Nature Chemical Biology, 18 (5), 482–491. 10.1038/s41589-022-00970-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Athanasopoulou K., Boti M. A., Adamopoulos P. G., Skourou P. C., Scorilas A. (2022). Third-generation sequencing: The spearhead towards the radical transformation of modern genomics. Life, 12 (1), 30, Article 1. 10.3390/life12010030 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ba F., Zhang Y., Wang L., Liu W.-Q., Li J. (2023). Applications of serine integrases in synthetic biology over the past decade. SynBio, 1 (2), 172–189, Article 2. 10.3390/synbio1020012 [DOI] [Google Scholar]
- Balagurunathan B., Ling H., Choi W. J., Chang M. W. (2022). Potential use of microbial engineering in single-cell protein production. Current Opinion in Biotechnology, 76, 102740. 10.1016/j.copbio.2022.102740 [DOI] [PubMed] [Google Scholar]
- Banerjee D., Eng T., Lau A. K., Sasaki Y., Wang B., Chen Y., Prahl J.-P., Singan V. R., Herbert R. A., Liu Y., Tanjore D., Petzold C. J., Keasling J. D., Mukhopadhyay A. (2020). Genome-scale metabolic rewiring improves titers rates and yields of the non-native product indigoidine at scale. Nature Communications, 11 (1), 5385. 10.1038/s41467-020-19171-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bauermeister A., Mannochio-Russo H., Costa-Lotufo L. V., Jarmusch A. K., Dorrestein P. C. (2022). Mass spectrometry-based metabolomics in microbiome investigations. Nature Reviews Microbiology, 20 (3), 143–160. 10.1038/s41579-021-00621-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Becker J., Wittmann C. (2018). From systems biology to metabolically engineered cells—An omics perspective on the development of industrial microbes. Current Opinion in Microbiology, 45, 180–188. 10.1016/j.mib.2018.06.001 [DOI] [PubMed] [Google Scholar]
- Beloqui A., De María P. D., Golyshin P. N., Ferrer M. (2008). Recent trends in industrial microbiology. Current Opinion in Microbiology, 11 (3), 240–248. 10.1016/j.mib.2008.04.005 [DOI] [PubMed] [Google Scholar]
- Bleem A., Kato R., Kellermyer Z. A., Katahira R., Miyamoto M., Niinuma K., Kamimura N., Masai E., Beckham G. T. (2023). Multiplexed fitness profiling by RB-TnSeq elucidates pathways for lignin-related aromatic catabolism in Sphingobium sp. SYK-6. Cell Reports, 42 (8), 112847. 10.1016/j.celrep.2023.112847 [DOI] [PubMed] [Google Scholar]
- Bludau I., Aebersold R. (2020). Proteomic and interactomic insights into the molecular basis of cell functional diversity. Nature Reviews Molecular Cell Biology, 21 (6), 327–340. 10.1038/s41580-020-0231-2 [DOI] [PubMed] [Google Scholar]
- Bock C., Datlinger P., Chardon F., Coelho M. A., Dong M. B., Lawson K. A., Lu T., Maroc L., Norman T. M., Song B., Stanley G., Chen S., Garnett M., Li W., Moffat J., Qi L. S., Shapiro R. S., Shendure J., Weissman J. S., Zhuang X. (2022). High-content CRISPR screening. Nature Reviews Methods Primers, 2 (1), 1–23. 10.1038/s43586-021-00093-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Borchert A. J., Bleem A., Beckham G. T. (2023). RB-TnSeq identifies genetic targets for improved tolerance of Pseudomonas putida towards compounds relevant to lignin conversion. Metabolic Engineering, 77, 208–218. 10.1016/j.ymben.2023.04.007 [DOI] [PubMed] [Google Scholar]
- Bradu P., Biswas A., Nair C., Sreevalsakumar S., Patil M., Kannampuzha S., Mukherjee A. G., Wanjari U. R., Renu K., Vellingiri B., Gopalakrishnan A. V. (2023). Recent advances in green technology and industrial revolution 4.0 for a sustainable future. Environmental Science and Pollution Research, 30 (60), 124488–124519. 10.1007/s11356-022-20024-4 [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
- Call S. N., Andrews L. B. (2022). CRISPR-based approaches for gene regulation in non-model bacteria. Frontiers in Genome Editing, 4, 892304. 10.3389/fgeed.2022.892304 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Camsund D., Lawson M. J., Larsson J., Jones D., Zikrin S., Fange D., Elf J. (2020). Time-resolved imaging-based CRISPRi screening. Nature Methods, 17 (1), 86–92. 10.1038/s41592-019-0629-y [DOI] [PubMed] [Google Scholar]
- Chiang A. J., Hasty J. (2023). Design of synthetic bacterial biosensors. Current Opinion in Microbiology, 76, 102380. 10.1016/j.mib.2023.102380 [DOI] [PubMed] [Google Scholar]
- Cho S., Shin J., Cho B.-K. (2018). Applications of CRISPR/Cas system to bacterial metabolic engineering. International Journal of Molecular Sciences, 19 (4), 1089, Article 4. 10.3390/ijms19041089 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Choi S. Y., Woo H. M. (2020). CRISPRi-dCas12a: A dCas12a-mediated CRISPR interference for repression of multiple genes and metabolic engineering in cyanobacteria. ACS Synthetic Biology, 9 (9), 2351–2361. 10.1021/acssynbio.0c00091 [DOI] [PubMed] [Google Scholar]
- Chu L. L. (2022). CRISPR-Cas system in microbial hosts for terpenoid production. Critical Reviews in Biotechnology, 42 (7), 1116–1133. 10.1080/07388551.2021.1995318 [DOI] [PubMed] [Google Scholar]
- Collias D., Beisel C. L. (2021). CRISPR technologies and the search for the PAM-free nuclease. Nature Communications, 12 (1), 555. 10.1038/s41467-020-20633-y [DOI] [PMC free article] [PubMed] [Google Scholar]
- Crits-Christoph A., Kang S. C., Lee H. H., Ostrov N. (2023). MicrobeMod: A computational toolkit for identifying prokaryotic methylation and restriction-modification with nanopore sequencing (p. 2023.11.13.566931). BioRxiv, 10.1101/2023.11.13.566931 bioRxiv [DOI] [Google Scholar]
- Cui L., Vigouroux A., Rousset F., Varet H., Khanna V., Bikard D. (2018). A CRISPRi screen in E. coli reveals sequence-specific toxicity of dCas9. Nature Communications, 9 (1), 1912. 10.1038/s41467-018-04209-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
- de Bakker V., Liu X., Bravo A. M., Veening J.-W. (2022). CRISPRi-seq for genome-wide fitness quantification in bacteria. Nature Protocols, 17 (2), 252–281. 10.1038/s41596-021-00639-6 [DOI] [PubMed] [Google Scholar]
- Dragosits M., Mattanovich D. (2013). Adaptive laboratory evolution—Principles and applications for biotechnology. Microbial Cell Factories, 12 (1), 64. 10.1186/1475-2859-12-64 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Elmore J. R., Dexter G. N., Baldino H., Huenemann J. D., Francis R., Peabody G. L., Martinez-Baird J., Riley L. A., Simmons T., Coleman-Derr D., Guss A. M., Egbert R. G. (2023). High-throughput genetic engineering of nonmodel and undomesticated bacteria via iterative site-specific genome integration. Science Advances, 9 (10), eade1285. 10.1126/sciadv.ade1285 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fatma Z., Schultz J. C., Zhao H. (2020). Recent advances in domesticating non-model microorganisms. Biotechnology Progress, 36 (5), e3008. 10.1002/btpr.3008 [DOI] [PubMed] [Google Scholar]
- Fenster J. A., Eckert C. A. (2021). High-throughput functional genomics for energy production. Current Opinion in Biotechnology, 67, 7–14. 10.1016/j.copbio.2020.09.010 [DOI] [PubMed] [Google Scholar]
- Fenster J. A., Werner A. Z., J. W. Tay, M. Gillen, L. Schirokauer, N. C. Hill, A. Watson, K. J. Ramirez, C. W. Johnson, G. T. Beckham, J. C. Cameron, C. A. Eckert. 2022. Dynamic and single cell characterization of a CRISPR-interference toolset in Pseudomonas putida KT2440 for β-ketoadipate production from p-coumarate, Metabolic Engineering Communications, 15, e00204. 10.1016/j.mec.2022.e00204 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fleck N., Grundner C. (2021). A Cas12a-based CRISPR interference system for multigene regulation in mycobacteria. Journal of Biological Chemistry, 297 (2), 100990. 10.1016/j.jbc.2021.100990 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Freed E., Fenster J., Smolinski S. L., Walker J., Henard C. A., Gill R., Eckert C. A. (2018). Building a genome engineering toolbox in nonmodel prokaryotic microbes. Biotechnology and Bioengineering, 115 (9), 2120–2138. 10.1002/bit.26727 [DOI] [PubMed] [Google Scholar]
- Hadley Kershaw E., Hartley S., McLeod C., Polson P. (2021). The sustainable path to a circular bioeconomy. Trends in Biotechnology, 39 (6), 542–545. 10.1016/j.tibtech.2020.10.015 [DOI] [PubMed] [Google Scholar]
- Heijstra B. D., Leang C., Juminaga A. (2017). Gas fermentation: Cellular engineering possibilities and scale up. Microbial Cell Factories, 16 (1), 60. 10.1186/s12934-017-0676-y [DOI] [PMC free article] [PubMed] [Google Scholar]
- Henke N. A., Göttl V. L., Schmitt I., Peters-Wendisch P., Wendisch V. F. (2022). A synthetic biology approach to study carotenoid production in Corynebacterium glutamicum: Read-out by a genetically encoded biosensor combined with perturbing native gene expression by CRISPRi. In Methods in Enzymology, 671, 383–419. Elsevier. 10.1016/bs.mie.2021.11.026 [DOI] [PubMed] [Google Scholar]
- Jervis A. J., Hanko E. K. R., Dunstan M. S., Robinson C. J., Takano E., Scrutton N. S. (2021). A plasmid toolset for CRISPR-mediated genome editing and CRISPRi gene regulation in Escherichia coli. Microbial Biotechnology, 14 (3), 1120–1129. 10.1111/1751-7915.13780 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Joseph R. C., Sandoval N. R. (2023). Single and multiplexed gene repression in solventogenic Clostridium via Cas12a-based CRISPR interference. Synthetic and Systems Biotechnology, 8 (1), 148–156. 10.1016/j.synbio.2022.12.005 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kaczmarzyk D., Cengic I., Yao L., Hudson E. P. (2018). Diversion of the long-chain acyl-ACP pool in Synechocystis to fatty alcohols through CRISPRi repression of the essential phosphate acyltransferase PlsX. Metabolic Engineering, 45, 59–66. 10.1016/j.ymben.2017.11.014 [DOI] [PubMed] [Google Scholar]
- Kim J., Shin B., Park C., Park W. (2017). Indole-induced activities of β-lactamase and efflux pump confer ampicillin resistance in Pseudomonas putida KT2440. Frontiers in Microbiology, 8, 243839. 10.3389/fmicb.2017.00433 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kong T., Backes N., Kalwa U., Legner C., Phillips G. J., Pandey S. (2019). Adhesive tape microfluidics with an autofocusing module that incorporates CRISPR interference: Applications to long-term bacterial antibiotic studies. ACS Sensors, 4 (10), 2638–2645. 10.1021/acssensors.9b01031 [DOI] [PubMed] [Google Scholar]
- Le Y., Sun J. (2022). CRISPR/Cas genome editing systems in thermophiles: Current status, associated challenges, and future perspectives. Advances in Applied Microbiology, 118, 1–30. 10.1016/bs.aambs.2022.02.001 [DOI] [PubMed] [Google Scholar]
- Lee H. H., Ostrov N., Wong B. G., Gold M. A., Khalil A. S., Church G. M. (2019). Functional genomics of the rapidly replicating bacterium Vibrio natriegens by CRISPRi. Nature Microbiology, 4 (7), 1105–1113. 10.1038/s41564-019-0423-8 [DOI] [PubMed] [Google Scholar]
- Leenay R. T., Beisel C. L. (2017). Deciphering, communicating, and engineering the CRISPR PAM. Journal of Molecular Biology, 429 (2), 177–191. 10.1016/j.jmb.2016.11.024 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Li S., Jendresen C. B., Grünberger A., Ronda C., Jensen S. I., Noack S., Nielsen A. T. (2016). Enhanced protein and biochemical production using CRISPRi-based growth switches. Metabolic Engineering, 38, 274–284. 10.1016/j.ymben.2016.09.003 [DOI] [PubMed] [Google Scholar]
- Li S., Jendresen C. B., Landberg J., Pedersen L. E., Sonnenschein N., Jensen S. I., Nielsen A. T. (2020). Genome-wide CRISPRi-based identification of targets for decoupling growth from production. ACS Synthetic Biology, 9 (5), 1030–1040. 10.1021/acssynbio.9b00143 [DOI] [PubMed] [Google Scholar]
- Li T., Zhang X., Luo F., Wu F.-X., Wang J. (2020). MultiMotifMaker: A multi-thread tool for identifying DNA methylation motifs from Pacbio Reads. IEEE /ACM Transactions on Computational Biology and Bioinformatics, 17 (1), 220–225. 10.1109/TCBB.2018.2861399 [DOI] [PubMed] [Google Scholar]
- Li Y., Pan S., Zhang Y., Ren M., Feng M., Peng N., Chen L., Liang Y. X., She Q. (2016). Harnessing type I and type III CRISPR-Cas systems for genome editing. Nucleic Acids Research, 44 (4), e34. 10.1093/nar/gkv1044 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lim H. G., Eng T., Banerjee D., Alarcon G., Lau A. K., Park M.-R., Simmons B. A., Palsson B. O., Singer S. W., Mukhopadhyay A., Feist A. M. (2021). Generation of Pseudomonas putida KT2440 strains with efficient utilization of xylose and galactose via adaptive laboratory evolution. ACS Sustainable Chemistry & Engineering, 9 (34), 11512–11523. 10.1021/acssuschemeng.1c03765 [DOI] [Google Scholar]
- Liu G., Lin Q., Jin S., Gao C. (2022). The CRISPR-Cas toolbox and gene editing technologies. Molecular Cell, 82 (2), 333–347. 10.1016/j.molcel.2021.12.002 [DOI] [PubMed] [Google Scholar]
- Liu S., Moon C. D., Zheng N., Huws S., Zhao S., Wang J. (2022). Opportunities and challenges of using metagenomic data to bring uncultured microbes into cultivation. Microbiome, 10 (1), 76. 10.1186/s40168-022-01272-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Liu X., Gallay C., Kjos M., Domenech A., Slager J., van Kessel S. P., Knoops K., Sorg R. A., Zhang J., Veening J. (2017). High-throughput CRISPRi phenotyping identifies new essential genes in Streptococcus pneumoniae. Molecular Systems Biology, 13 (5), 931. 10.15252/msb.20167449 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lu L., Shen X., Sun X., Yan Y., Wang J., Yuan Q. (2022). CRISPR-based metabolic engineering in non-model microorganisms. Current Opinion in Biotechnology, 75, 102698. 10.1016/j.copbio.2022.102698 [DOI] [PubMed] [Google Scholar]
- Ma E., Chen K., Shi H., Stahl E. C., Adler B., Trinidad M., Liu J., Zhou K., Ye J., Doudna J. A. (2022). Improved genome editing by an engineered CRISPR-Cas12a. Nucleic Acids Research, 50 (22), 12689–12701. 10.1093/nar/gkac1192 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mormino M., Lenitz I., Siewers V., Nygård Y. (2022). Identification of acetic acid sensitive strains through biosensor-based screening of a Saccharomyces cerevisiae CRISPRi library. Microbial Cell Factories, 21 (1), 214. 10.1186/s12934-022-01938-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mougiakos I., Bosma E. F., Ganguly J., van der Oost J., van Kranenburg R. (2018). Hijacking CRISPR-Cas for high-throughput bacterial metabolic engineering: Advances and prospects. Current Opinion in Biotechnology, 50, 146–157. 10.1016/j.copbio.2018.01.002 [DOI] [PubMed] [Google Scholar]
- Mueller J., Willett H., Feist A. M., Niu W. (2022). Engineering Pseudomonas putida for improved utilization of syringyl aromatics. Biotechnology and Bioengineering, 119 (9), 2541–2550. 10.1002/bit.28131 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nargotra P., Sharma V., Lee Y.-C., Tsai Y.-H., Liu Y.-C., Shieh C.-J., Tsai M.-L., Dong C.-D., Kuo C.-H. (2023). Microbial Lignocellulolytic enzymes for the effective valorization of lignocellulosic biomass: A review. Catalysts, 13 (1), 83, Article 1. 10.3390/catal13010083 [DOI] [Google Scholar]
- Noshay J. M., Walker T., Alexander W. G., Klingeman D. M., Romero J., Walker A. M., Prates E., Eckert C., Irle S., Kainer D., Jacobson D. A. (2023). Quantum biological insights into CRISPR-Cas9 sgRNA efficiency from explainable-AI driven feature engineering. Nucleic Acids Research, 51 (19), 10147–10161. 10.1093/nar/gkad736 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Orlando M., Molla G., Castellani P., Pirillo V., Torretta V., Ferronato N. (2023). Microbial enzyme biotechnology to reach plastic waste circularity: Current status, problems and perspectives. International Journal of Molecular Sciences, 24 (4), 3877. 10.3390/ijms24043877 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Peng Q., Bao W., Geng B., Yang S. (2024). Biosensor-assisted CRISPRi high-throughput screening to identify genetic targets in Zymomonas mobilis for high d-lactate production. Synthetic and Systems Biotechnology, 9 (2), 242–249. 10.1016/j.synbio.2024.02.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Price M. N., Wetmore K. M., Waters R. J., Callaghan M., Ray J., Liu H., Kuehl J. V., Melnyk R. A., Lamson J. S., Suh Y., Carlson H. K., Esquivel Z., Sadeeshkumar H., Chakraborty R., Zane G. M., Rubin B. E., Wall J. D., Visel A., Bristow J., Deutschbauer A. M. (2018). Mutant phenotypes for thousands of bacterial genes of unknown function. Nature, 557 (7706), 503–509. 10.1038/s41586-018-0124-0 [DOI] [PubMed] [Google Scholar]
- Riley L. A., Guss A. M. (2021). Approaches to genetic tool development for rapid domestication of non-model microorganisms. Biotechnology for Biofuels, 14 (1), 30. 10.1186/s13068-020-01872-z [DOI] [PMC free article] [PubMed] [Google Scholar]
- Riley L. A., Ji L., Schmitz R. J., Westpheling J., Guss A. M. (2019). Rational development of transformation in Clostridium thermocellum ATCC 27405 via complete methylome analysis and evasion of native restriction–modification systems. Journal of Industrial Microbiology and Biotechnology, 46 (9-10), 1435–1443. 10.1007/s10295-019-02218-x [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rousset F., Cui L., Siouve E., Becavin C., Depardieu F., Bikard D. (2018). Genome-wide CRISPR-dCas9 screens in E. coli identify essential genes and phage host factors. PLOS Genetics, 14 (11), e1007749. 10.1371/journal.pgen.1007749 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Roy R., Ray S., Chowdhury A., Anand R. (2021). Tunable multiplexed whole-cell biosensors as environmental diagnostics for ppb-level detection of aromatic pollutants. ACS Sensors, 6 (5), 1933–1939. 10.1021/acssensors.1c00329 [DOI] [PubMed] [Google Scholar]
- Saber Sichani A., Ranjbar M., Baneshi M., Torabi Zadeh F., Fallahi J. (2023). A review on advanced CRISPR-based genome-editing tools: Base editing and prime editing. Molecular Biotechnology, 65 (6), 849–860. 10.1007/s12033-022-00639-1 [DOI] [PubMed] [Google Scholar]
- Santos-Moreno J., Tasiudi E., Stelling J., Schaerli Y. (2020). Multistable and dynamic CRISPRi-based synthetic circuits. Nature Communications, 11 (1), 2746. 10.1038/s41467-020-16574-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Schilling C., Koffas M. A. G., Sieber V., Schmid J. (2020). Novel prokaryotic CRISPR-Cas12a-based tool for programmable transcriptional activation and repression. ACS Synthetic Biology, 9 (12), 3353–3363. 10.1021/acssynbio.0c00424 [DOI] [PubMed] [Google Scholar]
- Schultenkämper K., Brito L. F., Wendisch V. F. (2020). Impact of CRISPR interference on strain development in biotechnology. Biotechnology and Applied Biochemistry, 67 (1), 7–21. 10.1002/bab.1901 [DOI] [PubMed] [Google Scholar]
- Shen Y.-P., Pan Y., Niu F.-X., Liao Y.-L., Huang M., Liu J.-Z. (2022). Biosensor-assisted evolution for high-level production of 4-hydroxyphenylacetic acid in Escherichia coli. Metabolic Engineering, 70, 1–11. 10.1016/j.ymben.2021.12.008 [DOI] [PubMed] [Google Scholar]
- Shields R. C., Jensen P. A. (2019). The bare necessities: Uncovering essential and condition-critical genes with transposon sequencing. Molecular Oral Microbiology, 34 (2), 39–50. 10.1111/omi.12256 [DOI] [PubMed] [Google Scholar]
- Silvis M. R., Rajendram M., Shi H., Osadnik H., Gray A. N., Cesar S., Peters J. M., Hearne C. C., Kumar P., Todor H., Huang K. C., Gross C. A. (2021). Morphological and transcriptional responses to CRISPRi knockdown of essential genes in Escherichia coli. MBio, 12 (5), e02561–21. 10.1128/mBio.02561-21 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tadić V., Josipović G., Zoldoš V., Vojta A. (2019). CRISPR/Cas9-based epigenome editing: An overview of dCas9-based tools with special emphasis on off-target activity. Methods, 164-165, 109–119. 10.1016/j.ymeth.2019.05.003 [DOI] [PubMed] [Google Scholar]
- Todor H., Silvis M. R., Osadnik H., Gross C. A. (2021). Bacterial CRISPR screens for gene function. Current Opinion in Microbiology, 59, 102–109. 10.1016/j.mib.2020.11.005 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tourancheau A., Mead E. A., Zhang X.-S., Fang G. (2021). Discovering multiple types of DNA methylation from bacteria and microbiome using nanopore sequencing. Nature Methods, 18 (5), 491–498. 10.1038/s41592-021-01109-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Trivedi V., Ramesh A., Wheeldon I. (2023). Analyzing CRISPR screens in non-conventional microbes. Journal of Industrial Microbiology and Biotechnology, 50 (1), kuad006. 10.1093/jimb/kuad006 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Vento J. M., Crook N., Beisel C. L. (2019). Barriers to genome editing with CRISPR in bacteria. Journal of Industrial Microbiology and Biotechnology, 46 (9-10), 1327–1341. 10.1007/s10295-019-02195-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Volke D. C., Orsi E., Nikel P. I. (2023). Emergent CRISPR–Cas-based technologies for engineering non-model bacteria. Current Opinion in Microbiology, 75, 102353. 10.1016/j.mib.2023.102353 [DOI] [PubMed] [Google Scholar]
- Walker J. E., Lanahan A. A., Zheng T., Toruno C., Lynd L. R., Cameron J. C., Olson D. G., Eckert C. A. (2020). Development of both type I–B and type II CRISPR/Cas genome editing systems in the cellulolytic bacterium Clostridium thermocellum. Metabolic Engineering Communications, 10, e00116. 10.1016/j.mec.2019.e00116 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wang G., Li Q., Zhang Z., Yin X., Wang B., Yang X. (2023). Recent progress in adaptive laboratory evolution of industrial microorganisms. Journal of Industrial Microbiology and Biotechnology, 50 (1), kuac023. 10.1093/jimb/kuac023 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wang J., Li C., Jiang T., Yan Y. (2023). Biosensor-assisted titratable CRISPRi high-throughput (BATCH) screening for over-production phenotypes. Metabolic Engineering, 75, 58–67. 10.1016/j.ymben.2022.11.004 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wang J., Wei J., Li H., Li Y. (2022). High-efficiency genome editing of an extreme thermophile Thermus thermophilus using endogenous type I and type III CRISPR-Cas systems. mLife, 1 (4), 412–427. 10.1002/mlf2.12045 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wang T., Guan C., Guo J., Liu B., Wu Y., Xie Z., Zhang C., Xing X.-H. (2018). Pooled CRISPR interference screening enables genome-scale functional genomics study in bacteria with superior performance. Nature Communications, 9 (1), 2475. 10.1038/s41467-018-04899-x [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wang Y., Qian J., Shi T., Wang Y., Ding Q., Ye C. (2024). Application of extremophile cell factories in industrial biotechnology. Enzyme and Microbial Technology, 175, 110407. 10.1016/j.enzmictec.2024.110407 [DOI] [PubMed] [Google Scholar]
- Wetmore K. M., Price M. N., Waters R. J., Lamson J. S., He J., Hoover C. A., Blow M. J., Bristow J., Butland G., Arkin A. P., Deutschbauer A. (2015). Rapid quantification of mutant fitness in diverse bacteria by sequencing randomly bar-coded transposons. mBio, 6 (3), e00306-15. 10.1128/mbio.00306-15 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wu J., Gao P., Shi Y., Zhang C., Tong X., Fan H., Zhou X., Zhang Y., Yin H. (2023). Characterization of a thermostable Cas12a ortholog. Cell Insight, 2 (6), 100126. 10.1016/j.cellin.2023.100126 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wu Y., Chen T., Liu Y., Tian R., Lv X., Li J., Du G., Chen J., Ledesma-Amaro R., Liu L. (2020). Design of a programmable biosensor-CRISPRi genetic circuits for dynamic and autonomous dual-control of metabolic flux in Bacillus subtilis. Nucleic Acids Research, 48 (2), 996–1009. 10.1093/nar/gkz1123 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Xia P.-F., Ling H., Foo J. L., Chang M. W. (2019). Synthetic biology toolkits for metabolic engineering of Cyanobacteria. Biotechnology Journal, 14 (6), 1800496. 10.1002/biot.201800496 [DOI] [PubMed] [Google Scholar]
- Yang Z., Li Z., Li B., Bu R., Tan G.-Y., Wang Z., Yan H., Xin Z., Zhang G., Li M., Xiang H., Zhang L., Wang W. (2023). A thermostable type I-B CRISPR-Cas system for orthogonal and multiplexed genetic engineering. Nature Communications, 14 (1), 6193. 10.1038/s41467-023-41973-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ye D., Moon J. H., Jung G. Y. (2023). Recent progress in metabolic engineering of Escherichia coli for the production of various C4 and C5-dicarboxylic acids. Journal of Agricultural and Food Chemistry, 71 (29), 10916–10931, 10.1021/acs.jafc.3c02156 [DOI] [PubMed] [Google Scholar]
- Yeom J., Park J. S., Jung S.-W., Lee S., Kwon H., Yoo S. M. (2023). High-throughput genetic engineering tools for regulating gene expression in a microbial cell factory. Critical Reviews in Biotechnology, 43 (1), 82–99. 10.1080/07388551.2021.2007351 [DOI] [PubMed] [Google Scholar]
- Yin L., Xi D., Shen Y., Ding N., Shao Q., Qian Y., Fang Y. (2024). Rewiring metabolic flux in Corynebacterium glutamicum using a CRISPR/dCpf1-based bifunctional regulation system. Journal of Agricultural and Food Chemistry, 72 (6), 3077–3087. 10.1021/acs.jafc.3c08529 [DOI] [PubMed] [Google Scholar]
- Yu X., Li S., Feng H., Liao X., Xing X.-H., Bai Z., Liu X., Zhang C. (2023). CRISPRi-microfluidics screening enables genome-scale target identification for high-titer protein production and secretion. Metabolic Engineering, 75, 192–204. 10.1016/j.ymben.2022.12.004 [DOI] [PubMed] [Google Scholar]
- Yu Y., Gawlitt S., de Andrade e Sousa L. B., Merdivan E., Piraud M., Beisel C. L., Barquist L. (2024). Improved prediction of bacterial CRISPRi guide efficiency from depletion screens through mixed-effect machine learning and data integration. Genome Biology, 25 (1), 13. 10.1186/s13059-023-03153-y [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zhan C., Lee N., Lan G., Dan Q., Cowan A., Wang Z., Baidoo E. E. K., Kakumanu R., Luckie B., Kuo R. C., McCauley J., Liu Y., Valencia L., Haushalter R. W., Keasling J. D. (2023). Improved polyketide production in C. glutamicum by preventing propionate-induced growth inhibition. Nature Metabolism, 5 (7), 1127–1140. 10.1038/s42255-023-00830-x [DOI] [PubMed] [Google Scholar]
- Zhan Y., Xu Y., Zheng P., He M., Sun S., Wang D., Cai D., Ma X., Chen S. (2020). Establishment and application of multiplexed CRISPR interference system in Bacillus licheniformis. Applied Microbiology and Biotechnology, 104 (1), 391–403. 10.1007/s00253-019-10230-5 [DOI] [PubMed] [Google Scholar]
- Zhang P., Jiang D., Wang Y., Yao X., Luo Y., Yang Z. (2021). Comparison of de novo assembly strategies for bacterial genomes. International Journal of Molecular Sciences, 22 (14), 7668. 10.3390/ijms22147668 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zhang R., Xu W., Shao S., Wang Q. (2021). Gene silencing through CRISPR interference in bacteria: Current advances and future prospects. Frontiers in Microbiology, 12, 635227. 10.3389/fmicb.2021.635227 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zhao D., Zhu X., Zhou H., Sun N., Wang T., Bi C., Zhang X. (2021). CRISPR-based metabolic pathway engineering. Metabolic Engineering, 63, 148–159. 10.1016/j.ymben.2020.10.004 [DOI] [PubMed] [Google Scholar]
- Zhu D., Adebisi W. A., Ahmad F., Sethupathy S., Danso B., Sun J. (2020). Recent development of extremophilic bacteria and their application in biorefinery. Frontiers in Bioengineering and Biotechnology, 8, 483. 10.3389/fbioe.2020.00483 [DOI] [PMC free article] [PubMed] [Google Scholar]


